Purpose: Targeting of KIT and platelet-derived growth factor receptor (PDGFR) tyrosine
kinases by imatinib is an effective anticancer strategy. However, mutations of the gatekeeper …

Background Preterm birth affects almost 9–11% of newborns and is one of the leading
causes of childhood neurodevelopmental disabilities; the underlying molecular networks are …

Millions of infants are born prematurely every year worldwide. Prematurity, particularly at
lower gestational ages, is associated with high mortality and morbidity and is a significant …

Context: Anaplastic thyroid carcinomas (ATC) are among the most aggressive human
malignancies and are characterized by high mitotic activity. Minichromosome maintenance …

Necrotizing enterocolitis (NEC) is a devastating gut disease in preterm neonates. In NEC
animal models, mesenchymal stromal cells (MSCs) administration has reduced the incidence …

ZD6474 (vandetanib, Zactima, Astra Zeneca) is an anilinoquinazoline used to target the
receptor tyrosine kinase RET in familial and sporadic thyroid carcinoma (IC50: 100 nM). The aim …

Context: Mutations of the RET receptor tyrosine kinase are associated to multiple endocrine
neoplasia type 2 (MEN2) and sporadic medullary thyroid carcinoma (MTC). The heat shock …

Very preterm infants are exposed to prenatal inflammatory processes and early postnatal
hemodynamic and respiratory complications, but limited data are available about the …

Extracorporeal membrane oxygenation (ECMO) is a lifesaving support for respiratory and
cardiovascular failure. However, ECMO induces a systemic inflammatory response syndrome …

Background Early life adversity exposure impacts preterm infants’ neurodevelopment and
early intervention protocols may modulate neurodevelopmental outcomes. Neuronal genomes …